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ABSTRACT Bacteriophage Mu controls an unusual DNA-
modification function encoded by the mom gene, which is
located in an operon that consists oftwo overlapping genes. The
com gene, located proximal to the 5' end of the common mRNA
transcript, encodes a polypeptide of 62 amino acids that is
required for translation of mom. Analysis of the derived amino
acid sequence reveals that Com contains zinc-binding ringer
motifs, suggesting that Comr may be a zinc-activated regulatory
protein. Atomic absorption analysis showed that there is about
one zinc bound per molecule of Com. We have subcloned the
com gene into an expression vector and thus have overproduced
and purified the Com protein. By gel retardation analysis with
various 32P-labeled RNAs (made by in vitro transcription with
T7 RNA polymerase), we show that Com binds specifically to
com-mom mRNA. A single C -+ U substitution mutation,
located 26 nucleotides upstream from the mom translation start
codon, abolishes Com binding. The nature of the Com target
sequence was deduced from in vitro footprinting analyses. The
results are consistent with the existence of a complex stemroop
structure within the overlap of the com-mom open-reading-
frames. Comr binding to its target site results in the destabili-
zation of a proposed translation-inhibitor stemroop (TIS) to
expose the Shine-Dalgarno sequence and mom translation
initiation codon. This suggests that Com interaction with a
specific site on its cognate mRNA alters the mRRNA secondary
structure to activate translation of mom.
Bacteriophage Mu controls an unusual DNA-modification
function (1, 2) that protects viral DNA against cleavage by a
variety of site-specific DNA endonucleases (3, 4). The mom
gene is located at the right end of the Mu genetic map in an
operon comprising two overlapping genes. The com gene,
located proximal to the 5' end of the common mRNA
transcript, overlaps mom (see ref. 5 for review). Com is a
trans-acting positive regulator (6) that appears to act at the
level of translation of the mom open reading frame (ORF) (7,
8). Wulczyn et al. (9) used mom-lacZ translational fusion
plasmids to study the sequence requirements for Com regu-
lation. They proposed a model in which Com binding to a
specific region in the mom operon mRNA acted to relieve
translational repression caused by the presence of a transla-
tion-inhibitor stem-loop structure (denoted here as TIS)
within the overlap of the com-mom ORFs. From an analysis
of various deletion mutants, they concluded that the Com
target site is located in a short sequence located 5' to the TIS.
While our manuscript was in revision, these workers pro-
vided additional evidence for their model (10). We have
independently approached the study ofCom function through
an in vitro analysis of its interaction with com-mom mRNA.
We describe a procedure for purifying Com to near homo-
geneity and show that it is, in fact, a mom-specific mRNA-
binding protein. Footprinting studies demonstrate that (i) the
secondary structure of the target and TIS is more complex
than previously proposed, (ii) Com specifically binds to
com-mom mRNA at a site 5' to the putative TIS, and (iii)
Com binding destabilizes the mRNA secondary structure to
expose the Shine-Dalgarno (SD) ribosome-binding sequence
and mom start codon. Finally, consistent with the presence
of zinc-binding finger (11) motifs, physical analyses have
revealed that Com does indeed contain a tightly bound zinc
ion.T
MATERIALS AND METHODS
Bacterial Strains and Plasmids. Escherichia coli DH5a
[A(lac-arg)U169 endAl recAl hsdRJ7 supE thi gyrA relA
AR/F' 080dlacZAM15] was from BRL. E. coli RZ1032 {=
HfrKL PO/45 [lysA(61-62)] dut] ungi thil relAl Zbd-
279::TnJO supE44} (12) was from G. Pruss. E. coli C600-
(pcI857) and plasmid pCP40 (13) were from W. Fiers. Phage
M13rvl (14) and phagemid pGC2 (15) were from R. Myers.
Plasmid pT7T3-18 was from Pharmacia.
Enzymes and Fine Chemicals. T4 DNA ligase, T4 polynu-
cleotide kinase, and avian myeloblastosis virus reverse tran-
scriptase (RTase; United States Biochemical); RNase-free
DNase, placental RNase inhibitor, and T7 RNA polymerase
(BRL); E. coli DNA polymerase I Klenow fragment, Seph-
acryl S-100, and cobra venom RNase V1 (CV1) (Pharmacia);
[a-32P]UTP (Amersham); Geneclean (Bio 101, La Jolla, CA);
1-cyclohexyl-3-(2-morpholino)carbodiimide metho-p-tolue-
nesulfonate (CMCT) and Sephadex G-50 (Sigma); and dim-
ethyl sulfate (DMS; Aldrich) were purchased from the firms
indicated in parentheses. Oligodeoxyribonucleotides used in
site-directed mutagenesis were synthesized at the University
of Rochester sequencing facility.
Plasmid Construction. Plasmid pLW3 contains an EcoRI-
BamHI fragment, excised from a derivative of the mom-lacZ
fusion plasmid pMLF-2 (16), subcloned into the correspond-
ing sites of phagemid pGC2. A new EcoRI site was intro-
duced into pLW3 by site-directed mutagenesis (Fig. 1) be-
tween the com-mom promoter and the com SD sequence to
create pLW3RI. An intact com gene along with part ofmom
was excised from pLW3RI with EcoRI and BamHI and
cloned into pCP40 and pT7T3-18 to generate pLW40 and
pLW9, respectively (Fig. 1). Transcription of the com-mom
segment is controlled at the APL promoter in pLW40 and at
Abbreviations: CMCT, 1-cyclohexyl-3-(2-morpholino)carbodiimide
metho-p-toluenesulfonate; CV1, cobra venom RNase V1; DMS,
dimethyl sulfate; ORF, open reading frame; nt, nucleotide(s); SD,
Shine-Dalgarno; TIS, translation-inhibitor stem-loop; wt, wild type.
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EcoRl-BamHl fragment cloned into phagemid pGC2 = pLW3
New EcoRI site created by oligonucleotide mutagenesis = pLW3RI
EcoRl-BamHI fragment EcoRI-BamHl fragment
into pCP40 into pT7T3-18
= pLW40 = pLW9
[ XpL promoter] [T7 genelO promoter]
Com production In vitro transcripts
FIG. 1. Strategy for construction of recombinant plasmids for
overproduction of Com and for in vitro synthesis of labeled Mu
com-mom mRNA transcripts. See Materials and Methods for de-
tails.
the phage T7 gene 10 promoter in pLW9. In pLW40, expres-
sion from APL is regulated by the thermolabile cI857 repres-
sor encoded by plasmid pcI857.
Plasmid pLW9ABsm was derived as follows. pLW9 was
digested with Bsm I, which cleaves this plasmid at only two
sites, both located within the mom gene and separated by
about 50 nucleotides (nt). The resulting "overhangs" were
removed by S1 nuclease digestion and the plasmid was
recircularized by ligation. The C -+ U substitution at position
-26 was produced by oligonucleotide site-directed mutagen-
esis (12).
Labeling of in Vitro mRNA Transcripts. Plasmid DNA was
cleaved with Sal I and the unit-length fragment was purified.
In vitro production of labeled transcripts with T7 RNA
polymerase was according to the supplier's instructions. The
wild-type (wt) and -26 U transcripts are 369 nt long, whereas
the ABsm transcript is 319 nt. The 5' end of each transcript
contains an additional 9 nt (contributed by the vector) com-
pared with the native com-mom mRNA. The entire com ORF
and approximately one-third of the mom ORF (5' end) are
present on each transcript.
Gel Retardation Analysis. Com binding to labeled RNA was
monitored by gel retardation analysis. The binding reaction
mixture (10 ,ud) contained 50 mM Tris-HCl (pH 7.6), 50 mM
NaCl, 0.6 ng of 32P-labeled RNA (-1670 cpm/ng; 5 nM final
concentration), 12 ng of yeast tRNA, and various concen-
trations of Com (0.054-0.27 ,uM). After addition of Com to
start the reaction, incubation was at 22°C for 10 min, at which
time 2 ,A of loading buffer (0.25% bromophenol blue/0.25%
xylene cyanol/15% Ficoll) was added. Samples were sub-
jected to 5% PAGE with 89 mM Tris/89 mM boric acid at
22°C for 20 hr at 30 V.
Zinc Analysis. Atomic absorption spectroscopy using an
Instrumentation Laboratory (Lexington, MA) IL 57 spec-
trometer was performed by T. Pan in the laboratory of J. E.
Coleman.
Footprinting and Secondary Structure Analyses. Footprint-
ing and secondary structure analyses were carried out using
CMCT, DMS, and CV1 as probes. Reaction mixtures (50 ,ul;
50 mM Tris-HCI, pH 7.6/50 mM NaCI) contained 150 ng of
wt RNA (25 nM); see Fig. 5 for concentrations of Com and
agents. After 10 min of incubation with Com at 22°C, DMS,
CMCT, or CV1 was added (10 mM MgCI2 was included for
CV1 digestion). The reactions were quenched in stop buffer
after 60 min (final concentrations, 250 mM Tris'HCI, pH
7.6/500 mM NaCI/500 mM 2-mercaptoethanol/0.25 mM
Na2EDTA) and extracted successively with phenol and chlo-
roform/isoamyl alcohol, 24:1. The RNA was recovered after
ethanol precipitation and centrifugation. The pellets were
dried in vacuo and suspended in 2.1 A.l of primer extension
mixture (12 mM Tris acetate, pH 7.4/70 mM NH4CI/7 mM
2-mercaptoethanol with 2 ng of end-labeled sequencing prim-
er). After heating for 3 min at 650C, the primer was annealed
during rapid cooling at -800C over 30 min. Following the
addition of dNTPs (0.37 mM final for each) and Mg(OAc)2 (1
mM final), primer extension was started by the addition of 6
units of reverse transcriptase. After incubation for 15 min at
37TC, the reaction was terminated in standard formamide/
dye loading buffer with 30 mM Na2EDTA. The samples were
heated for 3 min at 95°C and subjected to 5% PAGE with 8
M urea. Control sequencing reactions were carried out in
parallel using pLW9 RNA (200 ng) and standard dideoxy-
NTP/dNTP mixtures.
RESULTS AND DISCUSSION
Overproduction and Purification of Com. E. coli DH5a
containing plasmids pLW40 and pcI857 was grown in drug-
selection medium at 28°C to an OD550 of 0.5. The temperature
was raised to 42°C and incubation continued for 3 hr. All
further operations were at 4°C. After low-speed centrifuga-
tion the cells were washed and resuspended in 20 mM
Tris-HCl, pH 8.0/5 mM MgCl2/7 mM 2-mercaptoethanol/1
mM Na2EDTA/1 mM phenylmethylsulfonyl fluoride. Fol-
lowing sonication and low-speed centrifugation, the pellet
(which contained Com, presumably in inclusion bodies) was
suspended in S buffer [20 mM Tris-HCI, pH 8.0/1 mM
Na2EDTA/25 mM NaCl/7 mM 2-mercaptoethanol/5% (vol/
vol) glycerol]. After washing the pellet, Com was solubilized
in HS buffer (S buffer with 1 M NaCl). The suspension was
clarified by centrifugation; Com was precipitated in 70%
saturated (NH4)2SO4 and harvested by centrifugation. The
resulting pellet was resuspended in HS buffer. Samples (1-1.5
ml) were subjected to gel filtration through a Sephacryl S-100
column (2.5 x 60 cm) equilibrated in MS buffer (S buffer with
0.5M NaCI). Selected Com-containing fractions (at least 95%
pure by SDS/PAGE and Coomassie blue staining; data not
shown) were pooled, concentrated by precipitation in 80%
saturated (NH4)2SO4, and stored in HS buffer at -80°C. Com
retained full RNA-binding activity for at least 6 months.
Amino-terminal sequence analysis was consistent with the
derived sequence predicted for Com. The yield was about 7
mg of Com per liter of cells based on the assay of Bradford
(17). However, amino acid composition analysis showed that
the Bradford assay overestimated Com concentration by a
factor of 2.5; hence, the protein concentrations given in the
text and figure legends represent corrected values.
Com Contains Equimolar Bound Zinc. Potential zinc-
binding finger motifs have been noted in a large number of
proteins, including E. coli aminoacyl-tRNA synthetases as
well as the gene 32 and UvrA proteins (11, 18). Examination
of the derived amino acid sequence revealed that there are
two such motifs present in Com. The first is CX2CX11HX4(C
or H), where C and H are the single-letter designations for
cysteine and histidine, respectively; X denotes any amino
acid. As seen in Fig. 2A, there are two such sequences in Mu
Com, arranged in tandem. One is CX2CX11HX4C (residues
6-26) and the other is CX2CX11HX4H (residues 26-46). In the
latter, CX2C is Cys-Pro-Arg-Cys, the same motiffound in the
E. coli isoleucyl-tRNA synthetase, which is known to bind its
cognate tRNA.
The second motif is CX2CX16CX2CX9CX7C (Fig. 2B; res-
idues 6-47) belonging to the Cx family (19). The sequence
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FIG. 2. Zinc-binding finger motifs in Mu Com. The entire derived
62-amino acid sequence is shown. (A) Motifs in which both the
cysteine and histidine side chains are used to coordinate a single zinc
ion. Two mutually exclusive, overlapping (at Cys-26) motifs are
boxed; stars denote tA ysteine and histidine residues capable of
serving as zinc ligands. The cysteine residue common to both motifs
is highlighted by stippling. (B) Motif in which cysteine residues only
(stars) are used to coordinate two zinc ions. The cysteine residues
that would serve as shared ligands are highlighted by stippling. A
variation of this motif is one in which His-41 and His-46 (denoted by
circles) are utilized in place of the flanking cysteine residues.
between the first and fourth cysteine residues is identical in
loop length to the motif found in E. coli isoleucyl-tRNA
synthetase, which binds zinc ion (20). However, two zinc
ions could be bound ifCys-26 and Cys-29 were used as shared
ligands to both ions. A variation of the second motif is
CX2CX16CX2CX11HX4H (residues 6-46); in Fig. 2B the car-
boxyl-terminal histidine residues, 41 and 46, are denoted with
circles.
In view of these considerations an atomic absorption
analysis of purified Com was carried out. The results indi-
a
cated 0.9 mol of zinc per mol of Com (data not shown). The
presence of tightly bound zinc was unambiguously demon-
strated by x-ray absorption fine spectroscopy, which showed
a strong zinc edge absorption at 9.659 keV as well as detailed
fine structure (J. Penner Hahn, R. Witkowski, G. McClen-
don, and S.H., unpublished work).
Com Binds Specifically to cor-mom mRNA. To analyze
whether Com interacts specifically with com-mom mRNA,
we carried out gel retardation assays with defined labeled
mRNAs made by in vitro transcription with 17 RNA poly-
merase. Binding to wt mRNA was compared with binding to
an internal deletion derivative, ABsm (see structure a in Fig.
3); the latter serves as a negative control because it lacks part
of the sequence required for Com recognition (9). As pre-
dicted, Com formed a specific complex with wt RNA, but not
with ABsm RNA (Fig. 4A). This suggests that Com binds
specifically to com-mom mRNA and that some internal
sequence is required for target recognition and binding. This
was confirmed by the inability of Com to bind mRNA
containing the single-base substitution -26 C to -26 U,
located 25 nt 5' to the mom start codon (Fig. 4B).
It should be noted that the transcripts used in these assays
were not full-length com-mom RNAs; however, the results
obtained with them indicate that they serve as a good model
system for studying Com interaction with the native tran-
script.
Footprinting and Secondary Structure Analyses. Wulczyn et
al. (9) proposed a model in which Com binding to a specific
target site on the com-mom mRNA destabilizes an adjacent
stem-loop structure (Fig. 3, structure a) to expose the SD
sequence and mom start codon; more recently (10), the
presence of an additional stem-loop was proposed (Fig. 3,
structure b). Our analysis suggests the existence of a more
complex structure (Fig. 3, structure c), which has a calculated
AG about 1.4 kcal/mol lower than that of structure b. To
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FIG. 3. Nucleotide sequence and pos-
sible secondary structures in the mRNA
within the com-mom ORF overlap.
Structure a is the structure originally
proposed (9) to contain the Com target
site and the adjacent stem-loop, denoted
TIS, which inhibits mom translation ini-
tiation. The likely mom ORF start codon,
GUG, is boxed. It is about 161 nt down-
stream from the normal com-mom
mRNA transcription initiation site. The
numbering of bases is with respect to the
5' G (+1) in the start codon. The hatched
rectangles underscore a pair of 11-mer
inverted repeats (9 of 11 nt match) not
noted in earlier analyses (9, 10); the solid
portion of the rectangle underscores a
perfect hexameric repeat. The extent of
the deletion produced by Bsm I and S1
nuclease treatments and the -26 C to
-26 U substitution are indicated. Struc-
ture b is a recently proposed (10) modi-
fication of structure a. Structure c is a
third possible secondary structure. The
11-mer inverted repeats create an addi-
tional stem region (containing the puta-
tive Com target) adjacent to the TIS.
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FIG. 4. Gel retardation analysis of Com binding to com-mom
mRNAs. Various amounts of purified Com were incubated with
32P-labeled wt, -26 U (369 nt), or ABsm (319 nt) RNAs. Reaction
mixtures were subjected to PAGE and the dried gels were autora-
diographed. Positions of free RNA and Com-RNA complexes are
indicated. Lane 1, no Com; lane 2, 0.054 /LM Com; lane 3, 0.108 ILM
Com; lane 4, 0.162 1LM Com; lane 5, 0.27 ,uM Com.
better understand the sequence and/or structure elements
required for Com interaction with com-mom mRNA, we
carried out in vitro footprinting analyses using chemical
probes (CMCT and DMS) and a secondary structure-specific
RNase (CV1). In unpaired regions, CMCT modifies Ni of
guanine and N3 of uracil (with a preference for U), whereas
DMS modifies N3 of cytosine and N1 of adenine (with a
preference for A); CV1 cleaves without base specificity
within paired regions, generating 3'-hydroxyl and 5'-phos-
phoryl termini. Sites modified with CMCT or DMS can be
identified by (end-labeled) primer extension with reverse
transcriptase, which terminates 1 nt prior to the modified
residue. Following PAGE analysis, these bands are displaced
by 1 nt (shorter) relative to corresponding fragments termi-
nated in the control dideoxy sequencing lanes (21, 22).
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To begin analyzing possible secondary structure(s) within
the com-mom overlap, we first used CV1 as a probe ofpaired
regions. In the absence of Com, CV1 cleaved sites in regions
corresponding to both the Com target and the TIS (Fig. SA).
This indicates there must be base pairing in both of these
regions, providing strong evidence for structure c. In con-
trast, when Com was present, CV1 cleavage at these sites
was inhibited. These results do not distinguish between the
possibility that Com bindingdestabilizes the paired regions or
that Com binds to and shields them from CV1 cleavage.
Moreover, the results do not indicate where Com actually
binds.
Therefore, we carried out a footprinting analysis using
CMCT as the probe. This agent modified primarily U resi-
dues at a variety of sites in both the target and TIS regions
(Fig. 5B). Because CMCT modifies unpaired bases, the
results suggest that structure c must be in equilibrium with
unpaired structures. [In this regard, Wulczyn and Kahmann
(10) observed that G residues located in the TIS and target
sites were sensitive to cleavage (to varying degrees) by T1
RNase; since this enzyme cleaves only at unpaired G resi-
dues, their results also support such an equilibrium.] How-
ever, when Com was present, there were CMCT-reactivity
enhancements at -25 U, +26 U, and +27 U. In contrast, -33
U, -29 U, and -17 U remained unreactive, despite desta-
bilization of the target stem and TIS; we suggest that Com
makes direct contact with these residues. This should be
contrasted with -36 U, which was always sensitive to
CMCT. Although U residues at -2, -1, and +2 were weakly
reactive in the absence ofCom and showed minimal enhance-
ment after addition of Com, the results are consistent with
structure c being the major species in the equilibrium mix-
ture. The protection afforded by Com at -33 U and -17 U
is not clearly visible in Fig. 5B; however, an excerpt ofresults
from a separate experiment shows this protection quite nicely
(Fig. 5C). We conclude that the 5' boundary of the Com
C
('Ccli
4
-4 ii:
4 ,x
Ui
4 2 i_.'
4 29 I
_~ 4Air..
4 s
FIG. 5. CMCT and CV1 prob-
ing of com-mom mRNA in the
400 ~ okpresence and absence of Com.
Various amounts of purified Com
were incubated with wt com-mom
* i * mRNA (25 nM) in the presence of
CV1 (4.5 x 10-4 units/ml (A) or
CMCT (1 mg/ml and 2 mg/ml in B
and C, respectively) (for CV1
cleavage, 10 mM Mg(OAc)2 was
included in the reaction). Com
was at 250 nM (+) or 500 nM
(++). CV1 sites cleaved only in
the absence of Com are indicated
(x). The results of two indepen-
dent CMCT-modification analy-
ses are shown in B and C; for
convenience, the sequencing gel
lanes are omitted, but the U posi-
tions are indicated. Anti-target de-
notes the sequence complemen-
tary to the one protected by Com
binding.
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FIG. 6. (A) Com contact sites deduced from chemical footprinting analyses. Small arrows are at sites whose reactivity to CMCT or DMS
was enhanced by Com; therefore, they are excluded as contact sites. Circled letters denote bases protected against the above agents by addition
of Com. Letters in squares denote Com-protected residues (10) for which we had no data. (B) Model describing Com interaction with com-mom
mRNA. Structure c is in equilibrium with a variety of possible stem-loop structures. Com binds to one that is similar to structure b (see Fig.
3), except for a slightly longer stem. This melts the shortened TIS and allows translation. Sites protected by Com binding are enclosed.
target site extends upstream to at least -33 U but stops
before -36 U; and the 3' boundary extends downstream to at
least -17 U. Analogous footprinting experiments were also
carried out with DMS. The results (not shown) are summa-
rized as follows. (i) In the absence of Com, DMS readily
modified all A and C residues in the unpaired regions of
structure c (except -19 C and -23 C). Residues +28 C, +25
A, +22 C, +21 A, -16 C, -23 C, -26 C, -27 C, -30 A, -31
A, and - 34 C, all predicted to be in paired regions of structure
c, were weakly (or not at all) reactive with DMS. This was
also observed in part by Wulczyn and Kahmann (10), but they
did not present data for +20 to +35. (ii) In the presence of
Com, there were enhancements of DMS reactivity at +28 C,
+25 A, +21 A, -12 C, -14 C, -15 C, and -23 C. These
results are consistent with the destabilization of both stems
in structure c, making A and C residues accessible to DMS.
In the presence of Com the weak reactivity seen at residues
-18 A, -21 A, -26 C, -27 C, -30 A, and -31 A was lost,
and -16 C remained unreactive, suggesting that Com inter-
acts directly with these bases. Consistent with this inference
is the fact that the -26 C to -26 U mutation abolishes Com
binding [from the gel retardation assay (Fig. 4), as well from
footprinting analysis (data not shown)]. From this we con-
clude that the 3' boundary of the Com target extends to -16
C.
Based on the protections against chemical modification, a
summary of the apparent Com contact sites is illustrated in
Fig. 6A. From this it is evident that Com protects only one
strand of the target stem in structure c. Thus, we must ask,
does Com bind the target stem and destabilize it, or does Com
bind some other structure that alters the equilibrium mixture?
One model for Com interaction with cor-mor mRNA is
shown in Fig. 6B. Verification ofthe model awaits analysis of
Com binding to transcripts with various mutations in the +20
to +30 region.
To our knowledge, Com is the smallest zinc-binding pro-
tein known, and it represents the first example ofa translation
factor that specifically binds its cognate mRNA and alters the
secondary structure without requiring ATP. In this regard, it
has been proposed that RNase III stimulates translation of
phage A cIII mRNA by binding to one of two alternative
structures, affecting the equilibrium in favor of the translat-
able form (23). Although the precise mechanism of Com
activation is not known, it is evident that the mom story
continues to grow in complexity and interest.
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